PRESS RELEASE

DDi Predict

Aureus Pharma has released DDI Predict, a software application to assess the risk of potential drug-drug interactions.

DDI Predict automatically calculates the risk of drug-drug interactions associated with Cytochrome P450s via a computer algorithm and provides in a manner of minutes, a graphical report containing all potential drug-drug interactions between a potential drug candidate and a large panel of other drugs/compounds. This analysis of potential DDI risk is based on the latest FDA risk classification.

The input to the application consists of experimental data for a proprietary compound and prior experimental knowledge derived from Aureus’ AurScope ADME knowledge database. This contains more than 16,000 compounds, 230,000 biological data points, analysed from more than 9,000 articles and FDA documents.

Company: 
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers